Guru Ownership Trend
Guru Analysis for Halozyme Therapeutics, Inc. (HALO)
Halozyme Therapeutics, Inc. (HALO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 10 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $221.67 M.
Top institutional holders include Cliff Asness and Renaissance Technologies.
Institutional sentiment is currently Bullish. This is evidenced by a $3.43 M net inflow during the quarter.
Recent activity highlights Jefferies Group who opened a new position. Conversely, Renaissance Technologies reduced exposure by 43.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Halozyme Therapeutics, Inc. (HALO)
Major holders include Cliff Asness ($77.96 M), Renaissance Technologies ($37.87 M), Ray Dalio ($37.79 M). According to the latest reported data, 10 tracked investment managers collectively hold approximately 3.48 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $3.43 M, with 8 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited HALO. The total reported sell value was $34.44 M.
Yes, 1 managers opened new positions in HALO, and 7 increased their existing holdings. The total reported buy value was $37.87 M.
